Literature DB >> 7889282

Interactions of chloroethylclonidine with rauwolscine- and prazosin-sensitive adrenoceptors in dog saphenous vein.

A M Low1, D M Bowdish, T R Prashad, V Gaspar.   

Abstract

1. alpha 1-Adrenoceptors have been classified pharmacologically into four subtypes (alpha 1A, alpha 1B, alpha 1C and alpha 1D) on the basis of their differential affinity for novel antagonists such as chloroethylclonidine (CEC). While CEC is considered an alpha 1B-adrenoceptor antagonist, our earlier studies revealed that it also acted like an agonist in the dog saphenous vein (DSV). The present study characterized the contraction induced by CEC in endothelium-denuded rings from DSV. 2. Concentration-response curves for CEC were constructed in the absence (EC50 value of 11.13 +/- 3.6 microM, n = 8) and presence of propranolol (beta-adrenoceptor antagonist, 30 nM), rauwolscine (alpha 2-adrenoceptor antagonist, 30 nM), prazosin (alpha 1-adrenoceptor antagonist, 30 nM) or methysergide (5HT2 antagonist, 30 nM) or both prazosin and rauwolscine. Pretreatment with methysergide (9.83 +/- 5.14 microM, n = 4) or propranolol (23.78 +/- 12.32 microM, n = 4) had no consistent effect. In the presence of rauwolscine, the concentration-response curve for CEC was significantly shifted to the right with an EC50 value of 48.82 +/- 13.2 microM (n = 8). In the presence of prazosin, the CEC concentration-response curve had an EC50 value of 29.12 +/- 6.42 microM (n = 8). Pretreatment with both prazosin and rauwolscine shifted the concentration-response curve for CEC to the right with an EC50 value of 72.67 +/- 10.69 microM (n = 8, P < 0.05). Maximum responses were significantly reduced only in tissues that were treated with both prazosin and rauwolscine. 3. CEC (100 microM) pretreatment abolished prazosin binding sites and reduced the Bmax for rauwolscine by 50% without affecting the Kd value or the Hill slope.4. In Ca2+-free Krebs solution containing 50 microM EGTA, CEC produced a small transient contraction,suggesting that it can mobilize internally-stored Ca2+ . Pretreatment with rauwolscine abolished the CEC-induced contraction in Ca2+-free medium; prazosin pretreatment reduced but did not abolish CEC response in Ca2+-free medium.5. Restoring Ca2+ (0.5-2.5 mM) to the extracellular solution increased CEC contraction in a concentration-dependent manner, reaching a plateau at around 1.5mM Ca2 . The contraction was insensitive to nicardipine (1 microM), a voltage-operated Ca2+ channel blocker, but was blocked in a concentration-dependent manner by the putative receptor-operated Ca2+ channel blockers, SK&F 96365(1-1O microM) and genistein, also a tyrosine kinase inhibitor (10-100 microM).6. We conclude that CEC acts on rauwolscine- and, to a less extent, prazosin-sensitive adrenoceptors inDSV to release internally stored Ca2+ and to open receptor-operated Ca2+ channels. The inhibitory effect on CEC-induced contraction that depended on external Ca2+ by genistein suggests a role forty rosine kinase in the regulation of dihydropyridine-insensitive Ca2+ entry.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889282      PMCID: PMC1510511          DOI: 10.1111/j.1476-5381.1994.tb17134.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Alpha-adrenoceptors in vascular smooth muscle: all is not well.

Authors:  E E Daniel; A G Shi; Z L Wang; Y Y Guan; K Hoo; E J Cragoe; C Y Kwan
Journal:  Blood Vessels       Date:  1991

Review 2.  A model for receptor-regulated calcium entry.

Authors:  J W Putney
Journal:  Cell Calcium       Date:  1986-02       Impact factor: 6.817

3.  ADP evokes biphasic Ca2+ influx in fura-2-loaded human platelets. Evidence for Ca2+ entry regulated by the intracellular Ca2+ store.

Authors:  S O Sage; R Reast; T J Rink
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

Review 4.  Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+.

Authors:  K P Minneman
Journal:  Pharmacol Rev       Date:  1988-06       Impact factor: 25.468

5.  SK&F 96365, a novel inhibitor of receptor-mediated calcium entry.

Authors:  J E Merritt; W P Armstrong; C D Benham; T J Hallam; R Jacob; A Jaxa-Chamiec; B K Leigh; S A McCarthy; K E Moores; T J Rink
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

6.  Relation between density (maximum binding) of alpha adrenoceptor binding sites and contractile response in four canine vascular tissues.

Authors:  A G Shi; C Y Kwan; E E Daniel
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

7.  Does in vitro activation of postsynaptic alpha 2-adrenoceptor utilize intracellular Ca2+ for contraction in dog saphenous vein?

Authors:  Y Y Guan; C Y Kwan; E E Daniel
Journal:  Can J Physiol Pharmacol       Date:  1989-09       Impact factor: 2.273

8.  An analytical approach to the preparation and characterization of subcellular membranes from canine mesenteric arteries.

Authors:  C Y Kwan; C R Triggle; A K Grover; R M Lee; E E Daniel
Journal:  Prep Biochem       Date:  1983

9.  Heterogeneity of alpha 1-adrenergic receptors revealed by chlorethylclonidine.

Authors:  C Han; P W Abel; K P Minneman
Journal:  Mol Pharmacol       Date:  1987-10       Impact factor: 4.436

10.  Chloroethylclonidine irreversibly activates postjunctional alpha 2-adrenoceptors in the dog saphenous vein.

Authors:  J P Nunes; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

View more
  3 in total

1.  Direct block of native and cloned (Kir2.1) inward rectifier K+ channels by chloroethylclonidine.

Authors:  R Barrett-Jolley; C Dart; N B Standen
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

2.  Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine.

Authors:  Christoph Altmann; Veronika Steenpass; Peter Czyborra; Peter Hein; Martin C Michel
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

3.  Unusual alpha-adrenoceptor subtype in canine saphenous vein: comparison to mesenteric vein.

Authors:  E E Daniel; A M Low; V Gaspar; H Lu-Chao; J Green; J Akrong; S Duerksen; C Soyka; C K Chen; J Boyd; C Y Kwan
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.